On WEDNESDAY, Evoke Pharma, Inc. (NASDAQ: EVOK) ended the last transaction at $0.87, with a change of -2.25%. The daily volume was calculated at 20017 shares. The company has a market worth of $20.39M. It holds an average volume of 168.09K shares. In 52-week session, the stock hit the peak level of -73.31% and touched to lowest level of 73.97%.
Evoke Pharma, Inc. (EVOK) recently reported its financial results for the third quarter ended September 30, 2019.
Third Quarter 2019 Financial Review
For the third quarter of 2019, net loss was about $1.6M, or $0.07 per share, contrast to a net loss of about $1.5M, or $0.09 per share for the third quarter of 2018.
Research and development expenses totaled about $0.8M for the third quarter of 2019, contrast to about $0.6M for the third quarter of 2018. Research and development expenses were primarily related to responding to requests for additional information from FDA for the Gimoti NDA and manufacturing registration batches of Gimoti.
For the third quarter of 2019, general and administrative expenses were about $0.8M contrast to about $0.9M for the third quarter of 2018.
Total operating expenses for the third quarter of 2019 were about $1.6M, contrast to total operating expenses of about $1.5M for the third quarter of 2018.
As of September 30, 2019, the Company’s cash and cash equivalents were about $6.5M.
Analyst recommendation for this stock stands at 3. The volatility in the previous week has experienced by 5.67% and observed of 7.78% in the previous month. 14.00% ownership is held by institutional investors while insiders hold ownership of 5.68%.